amphetamine and eticlopride

amphetamine has been researched along with eticlopride in 24 studies

Research

Studies (24)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (16.67)	18.2507
2000's	11 (45.83)	29.6817
2010's	8 (33.33)	24.3611
2020's	1 (4.17)	2.80

Authors

Authors	Studies
Galloway, MP; Tyler, CB	1
McGinty, JF; Wang, JQ	1
James, CL; Trugman, JM	1
Dalia, A; Uretsky, NJ; Wallace, LJ	1
Beninger, RJ; Bernstein, SN	1
Jones, S; Kauer, JA; Kornblum, JL	1
Rebec, GV; Timberlake, W; Tinsley, MR	1
Izzo, E; Koob, GF; Orsini, C; Pulvirenti, L	1
Creekmore, E; Steinmiller, CL; Suto, N; Tanabe, LM; Vezina, P	1
Andersen, SL; Chen, YC; Choi, JK; Jenkins, BG; Rosen, BR	1
Blokland, A; Lieben, C; Sik, A	1
Gold, SJ; McGinty, JF; Schwendt, M	1
Kauer, JA; Mair, RD	1
Janssen, MC; Pattij, T; Schoffelmeer, AN; van Gaalen, MM; Vanderschuren, LJ	1
Kiyatkin, EA; Windels, F	1
Berke, JD; Pettibone, JR; Wiltschko, AB	1
McGinty, JF; Shi, X	1
Burgess, CR; Gillis, L; Peever, JH; Tse, G	1
Cocker, PJ; Dinelle, K; Kornelson, R; Sossi, V; Winstanley, CA	1
Björklund, A; Carta, M; Fidalgo, C; Lisci, C; Shin, E; Stancampiano, R; Tronci, E	1
Beyer, JD; White, IM; White, W	1
Fitzgerald, CA; Jin, DZ; Mao, LM; Wang, JQ; Xue, B	1
De Luca, MA; Emanuele, M; Managò, F; Mastrogiacomo, R; Mastwal, S; Mereu, M; Papaleo, F; Scheggia, D; Wang, KH; Weinberger, DR	1
Chaudhri, N; Khoo, SY; Samaha, AN; Uhrig, A	1

Other Studies

24 other study(ies) available for amphetamine and eticlopride

Article	Year
Acute administration of amphetamine: differential regulation of dopamine synthesis in dopamine projection fields. The Journal of pharmacology and experimental therapeutics, 1992, Volume: 261, Issue:2 Topics: Amphetamine; Animals; Benzazepines; Brain; Chromatography, High Pressure Liquid; Dopamine; Drug Interactions; Injections, Subcutaneous; Male; Rats; Rats, Inbred Strains; Salicylamides	1992
Differential effects of D1 and D2 dopamine receptor antagonists on acute amphetamine- or methamphetamine-induced up-regulation of zif/268 mRNA expression in rat forebrain. Journal of neurochemistry, 1995, Volume: 65, Issue:6 Topics: Amphetamine; Animals; Behavior, Animal; Benzazepines; DNA-Binding Proteins; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Early Growth Response Protein 1; Immediate-Early Proteins; Male; Methamphetamine; Prosencephalon; Rats; Rats, Wistar; Receptors, Dopamine D1; RNA, Messenger; Salicylamides; Time Factors; Transcription Factors	1995
D1 dopamine agonist and antagonist effects on regional cerebral glucose utilization in rats with intact dopaminergic innervation. Brain research, 1993, Apr-02, Volume: 607, Issue:1-2 Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Animals; Autoradiography; Basal Ganglia; Benzazepines; Brain Chemistry; Deoxyglucose; Dopamine; Glucose; Male; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Salicylamides	1993
Dopaminergic agonists administered into the nucleus accumbens: effects on extracellular glutamate and on locomotor activity. Brain research, 1998, Mar-30, Volume: 788, Issue:1-2 Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Animals; Benzazepines; Caffeine; Central Nervous System Stimulants; Dopamine Agonists; Dopamine Antagonists; Glutamic Acid; Haloperidol; Male; Motor Activity; Nucleus Accumbens; Quinpirole; Rats; Rats, Sprague-Dawley; Salicylamides	1998
Turning in rats following intraaccumbens shell injections of amphetamine or eticlopride. Pharmacology, biochemistry, and behavior, 2000, Volume: 65, Issue:2 Topics: Amphetamine; Animals; Dopamine Agents; Dopamine Antagonists; Male; Motor Activity; Nucleus Accumbens; Rats; Rats, Wistar; Salicylamides	2000
Amphetamine blocks long-term synaptic depression in the ventral tegmental area. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2000, Aug-01, Volume: 20, Issue:15 Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Dopamine; Dopamine Antagonists; Electrophysiology; Long-Term Potentiation; Neural Inhibition; Neuronal Plasticity; Rats; Rats, Sprague-Dawley; Reward; Salicylamides; Synapses; Ventral Tegmental Area	2000
Facilitation of preparatory behavior in an artificial prey paradigm by D1-subfamily dopamine receptor activation. Behavioural brain research, 2000, Volume: 114, Issue:1-2 Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Benzazepines; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Female; Predatory Behavior; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Salicylamides	2000
A dopamine partial agonist and antagonist block amphetamine self-administration in a progressive ratio schedule. Pharmacology, biochemistry, and behavior, 2001, Volume: 68, Issue:4 Topics: Amphetamine; Animals; Conditioning, Operant; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dopamine Uptake Inhibitors; Infusions, Intravenous; Lisuride; Male; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D2; Reinforcement Schedule; Salicylamides; Self Administration	2001
Blockade of D2 dopamine receptors in the VTA induces a long-lasting enhancement of the locomotor activating effects of amphetamine. Behavioural pharmacology, 2004, Volume: 15, Issue:5-6 Topics: Amphetamine; Animals; Central Nervous System Stimulants; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Male; Motor Activity; Rats; Rats, Long-Evans; Receptors, Dopamine D2; Salicylamides; Ventral Tegmental Area	2004
Mapping dopamine D2/D3 receptor function using pharmacological magnetic resonance imaging. Psychopharmacology, 2005, Volume: 180, Issue:4 Topics: Amphetamine; Animals; Brain; Brain Mapping; Dopamine Agonists; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Ferric Compounds; Magnetic Resonance Imaging; Male; Oxygen; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Salicylamides; Time Factors	2005
Evaluation of DOI, 8-OH-DPAT, eticlopride and amphetamine on impulsive responding in a reaction time task in rats. Behavioural pharmacology, 2005, Volume: 16, Issue:2 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamine; Amphetamines; Animals; Central Nervous System Stimulants; Dopamine Antagonists; Dose-Response Relationship, Drug; Hallucinogens; Impulsive Behavior; Male; Motor Activity; Rats; Reaction Time; Salicylamides; Serotonin Receptor Agonists	2005
Acute amphetamine down-regulates RGS4 mRNA and protein expression in rat forebrain: distinct roles of D1 and D2 dopamine receptors. Journal of neurochemistry, 2006, Volume: 96, Issue:6 Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Benzazepines; Cerebral Cortex; Disease Models, Animal; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Down-Regulation; GTP-Binding Protein alpha Subunits, Gi-Go; GTP-Binding Protein alpha Subunits, Gq-G11; Male; Neostriatum; Prosencephalon; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; RGS Proteins; RNA, Messenger; Salicylamides; Signal Transduction	2006
Amphetamine depresses excitatory synaptic transmission at prefrontal cortical layer V synapses. Neuropharmacology, 2007, Volume: 52, Issue:1 Topics: Adrenergic alpha-Antagonists; Amphetamine; Animals; Benzazepines; Central Nervous System Stimulants; Dopamine; Dopamine Antagonists; Drug Interactions; Electric Stimulation; Excitatory Postsynaptic Potentials; In Vitro Techniques; Methiothepin; Neural Inhibition; Neurons; Patch-Clamp Techniques; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Salicylamides; Serotonin Antagonists; Synapses; Synaptic Transmission; Yohimbine	2007
Involvement of dopamine D1 and D2 receptors in the nucleus accumbens core and shell in inhibitory response control. Psychopharmacology, 2007, Volume: 191, Issue:3 Topics: Amphetamine; Animals; Attention; Behavior, Animal; Benzazepines; Central Nervous System Stimulants; Choice Behavior; Dopamine Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Impulsive Behavior; Inhibition, Psychological; Male; Nucleus Accumbens; Rats; Rats, Wistar; Reaction Time; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides	2007
Dopamine action in the substantia nigra pars reticulata: iontophoretic studies in awake, unrestrained rats. The European journal of neuroscience, 2006, Volume: 24, Issue:5 Topics: Action Potentials; Amphetamine; Animals; Benzazepines; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Immunohistochemistry; Iontophoresis; Male; Motor Activity; Neurons; Rats; Rats, Long-Evans; Salicylamides; Substantia Nigra; Tyrosine 3-Monooxygenase; Wakefulness	2006
Opposite effects of stimulant and antipsychotic drugs on striatal fast-spiking interneurons. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2010, Volume: 35, Issue:6 Topics: Action Potentials; Amphetamine; Animals; Antipsychotic Agents; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Efferent Pathways; Interneurons; Male; Motor Activity; Neostriatum; Rats; Rats, Long-Evans; Salicylamides	2010
D1 and D2 dopamine receptors differentially mediate the activation of phosphoproteins in the striatum of amphetamine-sensitized rats. Psychopharmacology, 2011, Volume: 214, Issue:3 Topics: Amphetamine; Animals; Area Under Curve; Behavior, Animal; Benzazepines; Central Nervous System Stimulants; Corpus Striatum; CREB-Binding Protein; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Dyskinesia, Drug-Induced; Exploratory Behavior; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Hyperkinesis; Male; Motor Activity; Oncogene Protein v-akt; Phosphoproteins; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Statistics as Topic; Stereotyped Behavior; Time Factors	2011
Dopaminergic regulation of sleep and cataplexy in a murine model of narcolepsy. Sleep, 2010, Volume: 33, Issue:10 Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Analysis of Variance; Animals; Behavior, Animal; Benzazepines; Cataplexy; Disease Models, Animal; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Electroencephalography; Electromyography; Male; Mice; Mice, Knockout; Narcolepsy; Quinpirole; Receptors, Dopamine; Salicylamides; Sleep; Videotape Recording	2010
Irrational choice under uncertainty correlates with lower striatal D(2/3) receptor binding in rats. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2012, Oct-31, Volume: 32, Issue:44 Topics: Amphetamine; Animals; Autoradiography; Benzazepines; Choice Behavior; Conditioning, Operant; Dopamine Antagonists; Dopamine Uptake Inhibitors; Gambling; Individuality; Male; Neostriatum; Positron-Emission Tomography; Rats; Rats, Long-Evans; Receptors, Dopamine D2; Receptors, Dopamine D4; Reward; Risk-Taking; Salicylamides; Uncertainty	2012
The anti-dyskinetic effect of dopamine receptor blockade is enhanced in parkinsonian rats following dopamine neuron transplantation. Neurobiology of disease, 2014, Volume: 62 Topics: Amphetamine; Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Benzazepines; Buspirone; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dopaminergic Neurons; Dyskinesia, Drug-Induced; Female; Indoles; Levodopa; Mesencephalon; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Serotonin Receptor Agonists	2014
Acute withdrawal-related hypophagia elicited by amphetamine is attenuated by pretreatment with selective dopamine D1 or D2 receptor antagonists in rats. Physiology & behavior, 2015, Nov-01, Volume: 151 Topics: Amphetamine; Analysis of Variance; Animals; Anorexia; Benzazepines; Central Nervous System Stimulants; Conditioning, Operant; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Feeding Behavior; Male; Rats; Rats, Wistar; Salicylamides; Time Factors	2015
Amphetamine elevates phosphorylation of eukaryotic initiation factor 2α (eIF2α) in the rat forebrain via activating dopamine D1 and D2 receptors. Brain research, 2016, 09-01, Volume: 1646 Topics: Amphetamine; Animals; Benzazepines; Central Nervous System Stimulants; Corpus Striatum; Dopamine D2 Receptor Antagonists; Eukaryotic Initiation Factor-2; Male; Phosphorylation; Prefrontal Cortex; Prosencephalon; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides	2016
Genetic Disruption of Arc/Arg3.1 in Mice Causes Alterations in Dopamine and Neurobehavioral Phenotypes Related to Schizophrenia. Cell reports, 2016, 08-23, Volume: 16, Issue:8 Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Animals; Cognitive Dysfunction; Corpus Striatum; Cytoskeletal Proteins; Disease Models, Animal; Dopamine; Dopamine Agonists; Dopamine Antagonists; Female; Gene Expression; Male; Mice; Mice, Knockout; Nerve Tissue Proteins; Phenotype; Prefrontal Cortex; Psychomotor Disorders; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Schizophrenia; Sensory Gating; Synaptic Transmission	2016
Effects of dopamine receptor antagonism and amphetamine-induced psychomotor sensitization on sign- and goal-tracking after extended training. Behavioural brain research, 2021, 06-11, Volume: 407 Topics: Amphetamine; Animals; Behavior, Animal; Benzazepines; Central Nervous System Sensitization; Conditioning, Classical; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Goals; Locomotion; Male; Psychomotor Performance; Rats; Rats, Long-Evans; Receptors, Dopamine D1; Salicylamides	2021